Variant metabolic risk factor profile leading to premature coronary disease: Time to define the syndrome of accelerated atherocoronary metabolic syndrome in Asian Indians

Singapore Medical Journal

Volumn 50, Issue 10, 2009, Pages 949-955

  Jayasinghe, S Rohan ^a   Jayasinghe, S H ^b  

^a GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

Atherosclerosis; Cardiovascular prevention; Coronary artery disease; Metabolic syndrome

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN A;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ECONOMIC ASPECT; ETHNICITY; HUMAN; HYPERINSULINEMIA; INCIDENCE; INDIAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; OBESITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIABETES COMPLICATIONS; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INDIA; MALE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; TREATMENT OUTCOME;

EID: 74549171647     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Gupta R, Joshi P, Mohan V, Reddy KS, Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India. Heart 2008; 94:16-26.
2. Dawber TR, Kannel WB, Revotskie N, et al. Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study. Am J Public Health Nations Health 1959; 49:1349-56.
3. Singh RB, Dubnov G, Niaz MA et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet 2002; 360:1455-61.
4. Enas EA, Garg A, Davidson M, et al. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J 1996; 48:343-53.
5. Gupta R. Recent trends in coronary heart disease epidemiology in India. Indian Heart J 2008; 60(2 Suppl B):B4-18.
6. Gaziano TA. Is the horse already out of the barn in rural India? Circulation 2009; 119:1850-2.
7. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993; 87:152-61.
8. Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000; 356:279-84.
9. Kooner J. Coronary heart disease in the UK Indian Asians: the potential for reducing mortality. Heart 1997; 78:530-2.
10. Bahl VK, Vaswani M, Thatai D, Wasir HS. Plasma levels of apolipoproteins A-1 and B in Indian patients with angiographically defined coronary artery disease Int J Cardiol 1994; 46:143-9.
11. Forouhi N, McKeigue P. How far can risk factors account for excess coronary mortality in South Asians? Can J Cardiol 1997; 13:47B.
12. Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001; 86:5366-71.
13. Refsum H, Yajnik CS, Gadkari M, et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 2001; 74:233-41.
14. Scanu AM. Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function. J Lab Clin Med 1990; 116:142-6.
15. Anand SS, Enas EA, Pogue J, et al. Elevated lipoprotein(a) levels in South Asians in North America. Metabolism 1998; 47:182-4.
16. Low PS, Heng CK, Saha N, Tay JS. Racial variation of cord plasma lipoprotein(a) levels in relation to coronary risk level: a study in three ethnic groups in Singapore. Pediatr Res 1996; 40:718-22.
17. Cobbaert C, Jukema JW, Zwinderman AH, et al. Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Regression Growth Evaluation Statin Study (REGRESS) Study Group. J Am Coll Cardiol 1997; 30:1491-9.
18. Gupta R, Vasisht S, Bahl VK, wasir HS. Correlation of lipoprotein(a) to angiographically defined coronary artery disease in Indians. Int J Cardiol 1996; 57:265-70.
19. Retnakaran R, Hanley AJG, Zinman B. Does hypoadiponectinaemia explain the increased risk of diabetes and cardiovascular disease in South Asians? Diabetes Care 2006; 29:1950-4.
20. Zornitzki T, Reshef N, Ayzenberg O, et al. High-molecular weight adiponectin is associated with coronary artery angiographic findings in Asian Indians. Metabolism 2009; 58:632-7.
21. Teoh M, Lalondrelle S, Roughton M, Grocott-Mason R, Dubrey SW. Acute coronary syndromes and their presentation in Asian and Caucasian patients in Britain. Heart 2007; 93:183-8.
22. Zimmerman FH, Cameron A, Fisher LD, Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (coronary artery surgery Study Registry). J Am Coll Cardiol 1995; 26:654-61.
23. Enas EA. Avoiding premature coronary deaths in Asians in Britain: Guidelines for pharmacological intervention are needed. BMJ 1996; 312:376.
24. Enas EA, Dhawan J, Petkar S. Coronary artery disease in Asian Indians: lessons learned and the role of lipoprotein(a). Indian Heart J 1997; 49:25-34.
25. Britton A, Shipley M, Marmot M, Hemingway H. Does access to cardiac investigation and treatment contribute to social and ethnic differences in coronary heart disease? Whitehall II prospective cohort study. BMJ 2004; 329:318.
26. Dhawan J, Bray CL. Are Asian coronary arteries smaller than Caucasian? A study on angiographic coronary artery size estimation during life. Int J Cardiol 1995; 49:267-9.
27. Reddy KK, Rao AP, Reddy TP. Socioeconomic status and the prevalence of coronary heart disease risk factors. Asia Pac J Clin Nutr 2002; 11:98-103.
28. Chambers JC, Ireland H, Thompson E, et al. Methylenetetrahydrofolate reductase 677 C→T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol 2000; 20:2448-52.
29. Sanghera C, Aston N, Saha M, Kamboh MI. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am J Hum Genet 1998; 62:36-44.
30. Kylin E. [Studies of the hypertension-hyperglycaemia-hyperuricaemia syndrome]. Zentralbl Inn Med Leipzig 1923; 44:105-27. German.
31. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23:469-80.
32. Zimmet PZ, Alberti KG, Shaw JE. Mainstreaming the metabolic syndrome: a definitive definition. Med J Aust 2005; 183:175-6.
33. Expert Panel on Detection, Evaluation, and Treatment Of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
34. Yusuf S, Hawken S, Ounpuu S, et al. Effects of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-52.
35. Joshi R, Jan S, Wu Y, MacMahon S. Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coll Cardiol 2008; 52:1817-25.
36. Enas EA, Senthilkumar A, Vinod C, Puthumana N. Dyslipidaemia among Indo-Asians strategies for identification and management. Br J Diab Vasc Dis 2005; 5:81-90.
37. Chandalia M, Abate N, Cabo-Chan AV Jr, et al. Hyperhomocystinemia in Asian Indians living in the United States. J Clin Endocrin Metab 2003; 88:1089-95.